Risk for Rehospitalization Higher for Patients With Takotsubo Syndrome
FRIDAY, March 28, 2025 -- Patients with takotsubo syndrome have increased risk for rehospitalization compared with the general population, according to a research letter published online March 25 in the Annals of Internal Medicine.
Amelia E. Rudd, from the University of Aberdeen and NHS Grampian in the United Kingdom, and colleagues examined the incidence and causes of all subsequent hospital readmissions affecting patients with takotsubo syndrome in a cohort study. Unselected cases of patients with takotsubo syndrome (620 patients) were matched to control participants, selected based on age, sex, and geographic location from the Scottish general population (2,480 controls), and to patients with acute myocardial infarction (620 patients).
Of the 12,873 hospitalizations, the incidence rate of hospital readmissions was 743, 365, and 750 per 1,000 person-years for patients with takotsubo syndrome, controls from the general population, and patients with myocardial infarction, respectively. Patients with takotsubo syndrome were twice as likely to be hospitalized for any cause (hazard ratio, 1.96) and especially for cardiovascular causes, such as myocardial infarction, heart failure, or arrhythmia, compared with the general population. Excess admissions were seen for mental health, stroke, pulmonary, neurologic, infectious, gastrointestinal, and peripheral vascular disease causes. Patients with takotsubo syndrome had lower admission rates for myocardial infarction, heart failure, and arrhythmia but similar admission rates for stroke and mental health compared with those with myocardial infarction.
"This highlights these patients' increased vulnerability and a need for better discharge advice, clinical follow-up, and a focused search for therapeutic strategies directed to the specific pathophysiology of this condition," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Parent-Focused Interventions Do Not Prevent Obesity at Age 24 Months
TUESDAY, Sept. 16, 2025 -- Parent-focused behavioral interventions seem to be insufficient for preventing obesity at age 24 months, according to a review published online Sept. 10...
Half Discontinue Semaglutide for Weight Loss Within One Year
TUESDAY, Sept. 16, 2025 -- Half of adults who start semaglutide for weight loss discontinue within a year, according to a study presented at the annual meeting of the European...
Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment
MONDAY, Sept. 15, 2025 -- In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.